Melo, Rita de Cássia Carvalho <br/><br/>
CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12.  [electronic resource] 

 -  PloS one  2014 
 - e85926 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0085926  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Benzylamines<br/>Blotting, Western<br/>Bone Marrow--metabolism<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Chemokine CXCL12--pharmacology<br/>Cyclams<br/>Female<br/>Flow Cytometry<br/>Gene Expression Regulation, Leukemic--drug effects<br/>Heterocyclic Compounds--pharmacology<br/>Humans<br/>Jurkat Cells<br/>K562 Cells<br/>Leukocytes--metabolism<br/>Male<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--blood<br/>RNA Interference<br/>Receptors, CXCR--blood<br/>Receptors, CXCR4--antagonists & inhibitors<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>U937 Cells<br/>Young Adult